{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T01:40:54Z","timestamp":1771638054191,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["18427"],"award-info":[{"award-number":["18427"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"DOI":"10.1186\/s13550-025-01240-8","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T02:57:10Z","timestamp":1745809030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Spatial distribution of fractionally administered holmium microspheres in non-tumorous human liver tissue: how livers survive transarterial radioembolisation"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7875-9135","authenticated-orcid":false,"given":"Anne","family":"van den Brekel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4403-7916","authenticated-orcid":false,"given":"Tess J.","family":"Snoeijink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7900-5917","authenticated-orcid":false,"given":"Vincent E.","family":"de Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5951-1008","authenticated-orcid":false,"given":"Milou","family":"Boswinkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6345-653X","authenticated-orcid":false,"given":"Koert P.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7965-6664","authenticated-orcid":false,"given":"Joey","family":"Roosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5613-6084","authenticated-orcid":false,"given":"Alexandra G.","family":"Arranja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6800-2879","authenticated-orcid":false,"given":"Jurgen J.","family":"F\u00fctterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2298-689X","authenticated-orcid":false,"given":"Simeon J. S.","family":"Ruiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7625-2253","authenticated-orcid":false,"given":"J. Frank W.","family":"Nijsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"1240_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/17588359241280692","volume":"16","author":"A Mansur","year":"2024","unstructured":"Mansur A, Habibollahi P, Fang A, Mahvash A, Etezadi V, Liddell RP, et al. New frontiers in radioembolization. Therapeutic Adv Med Oncol. 2024;16:1\u201322. https:\/\/doi.org\/10.1177\/17588359241280692.","journal-title":"Therapeutic Adv Med Oncol"},{"key":"1240_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules26133966","volume":"26","author":"P d\u2019Abadie","year":"2021","unstructured":"d\u2019Abadie P, Hesse M, Louppe A, Lhommel R, Walrand S, Jamar F. Microspheres used in liver radioembolization: from conception to clinical effects. Molecules. 2021;26:1\u201314. https:\/\/doi.org\/10.3390\/molecules26133966.","journal-title":"Molecules"},{"key":"1240_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2014.00210","volume":"4","author":"M Cremonesi","year":"2014","unstructured":"Cremonesi M, Chiesa C, Strigari L, Ferrari M, Botta F, Guerriero F, et al. Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective. Front Oncol. 2014;4:1\u201320. https:\/\/doi.org\/10.3389\/fonc.2014.00210.","journal-title":"Front Oncol"},{"key":"1240_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1089\/sct.1991.7.39","volume":"7","author":"KM Pillai","year":"1991","unstructured":"Pillai KM, McKeever PE, Knutsen CA, Terrio PA, Prieskorn DM, Ensminger WD. Microscopic analysis of arterial microsphere distribution in rabbit liver and hepatic VX2 tumor. Select Cancer Therapeutics. 1991;7:39\u201348. https:\/\/doi.org\/10.1089\/sct.1991.7.39.","journal-title":"Select Cancer Therapeutics"},{"key":"1240_CR5","first-page":"735","volume":"33","author":"P Roberson","year":"1992","unstructured":"Roberson P, Ten Haken R, McShan D, McKeever P, Ensminger W. Three-dimensional tumor dosimetry for hepatic yttrium-90-microsphere therapy. J Nuclear Med. 1992;33:735\u20138.","journal-title":"J Nuclear Med"},{"key":"1240_CR6","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s00259-008-0747-8","volume":"35","author":"MA Vente","year":"2008","unstructured":"Vente MA, Nijsen JF, de Wit TC, Seppenwoolde JH, Krijger GC, Seevinck PR, et al. Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly (L-lactic acid) microspheres in healthy pigs. Eur J Nucl Med Mol Imaging. 2008;35:1259\u201371. https:\/\/doi.org\/10.1007\/s00259-008-0747-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1240_CR7","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1007\/s00259-019-04588-x","volume":"47","author":"AS Pasciak","year":"2020","unstructured":"Pasciak AS, Abiola G, Liddell RP, Crookston N, Besharati S, Donahue D, et al. The number of microspheres in Y90 radioembolization directly affects normal tissue radiation exposure. Eur J Nucl Med Mol Imaging. 2020;47:816\u201327. https:\/\/doi.org\/10.1007\/s00259-019-04588-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1240_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2967\/jnumed.113.126839","volume":"55","author":"S Walrand","year":"2014","unstructured":"Walrand S, Hesse M, Chiesa C, Lhommel R, Jamar F. The low hepatic toxicity per gray of 90Y Glass microspheres is linked to their transport in the arterial tree favoring a nonuniform trapping as observed in posttherapy PET imaging. J Nucl Med. 2014;55:135\u201340. https:\/\/doi.org\/10.2967\/jnumed.113.126839.","journal-title":"J Nucl Med"},{"key":"1240_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/0360-3016(91)90797-8","volume":"21","author":"R Fox","year":"1991","unstructured":"Fox R, Klemp P, Egan G, Mina L, Burton M, Gray B. Dose distribution following selective internal radiation therapy. Int J Radiation Oncol*Biol*Phys. 1991;21:463\u20137. https:\/\/doi.org\/10.1016\/0360-3016(91)90797-8.","journal-title":"Int J Radiation Oncol*Biol*Phys"},{"key":"1240_CR10","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1088\/0031-9155\/45\/4\/316","volume":"45","author":"AM Campbell","year":"2000","unstructured":"Campbell AM, Bailey IH, Burton MA. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol. 2000;45:1023\u201333. https:\/\/doi.org\/10.1088\/0031-9155\/45\/4\/316.","journal-title":"Phys Med Biol"},{"key":"1240_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1088\/0031-9155\/46\/2\/315","volume":"46","author":"AM Campbell","year":"2001","unstructured":"Campbell AM, Bailey IH, Burton MA. Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol. 2001;46:487\u201398. https:\/\/doi.org\/10.1088\/0031-9155\/46\/2\/315.","journal-title":"Phys Med Biol"},{"key":"1240_CR12","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.ijrobp.2004.09.004","volume":"60","author":"AS Kennedy","year":"2004","unstructured":"Kennedy AS, Nutting C, Coldwell D, Gaiser J, Drachenberg C. Pathologic response and microdosimetry of 90Y microspheres in man: Review of four explanted whole livers. Int J Radiation Oncol*Biol*Phys. 2004;60:1552\u201363. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.09.004.","journal-title":"Int J Radiation Oncol*Biol*Phys"},{"key":"1240_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13550-014-0048-0","volume":"4","author":"J H\u00f6gberg","year":"2014","unstructured":"H\u00f6gberg J, Rizell M, Hultborn R, Svensson J, Henrikson O, M\u00f6lne J, et al. Heterogeneity of microsphere distribution in resected liver and tumour tissue following selective intrahepatic radiotherapy. EJNMMI Res. 2014;4:1\u20139. https:\/\/doi.org\/10.1186\/s13550-014-0048-0.","journal-title":"EJNMMI Res"},{"key":"1240_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40658-015-0113-4","volume":"2","author":"J H\u00f6gberg","year":"2015","unstructured":"H\u00f6gberg J, Rizell M, Hultborn R, Svensson J, Henrikson O, M\u00f6lne J, Gjertsson P, Bernhardt P. Increased absorbed liver dose in Selective Internal Radiation Therapy (SIRT) correlates with increased sphere-cluster frequency and absorbed dose inhomogeneity. EJNMMI Phys. 2015;2:1\u201317. https:\/\/doi.org\/10.1186\/s40658-015-0113-4.","journal-title":"EJNMMI Phys"},{"key":"1240_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2191-219x-3-57","volume":"3","author":"Y-H Kao","year":"2013","unstructured":"Kao Y-H, Steinberg JD, Tay Y-S, Lim GK, Yan J, Townsend DW, et al. Post-radioembolization yttrium-90 PET\/CT-part 2: dose-response and tumor predictive dosimetry for resin microspheres. EJNMMI Res. 2013;3:1\u201312. https:\/\/doi.org\/10.1186\/2191-219x-3-57.","journal-title":"EJNMMI Res"},{"key":"1240_CR16","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s12149-013-0726-4","volume":"27","author":"M D\u2019Arienzo","year":"2013","unstructured":"D\u2019Arienzo M, Filippi L, Chiaramida P, Chiacchiararelli L, Cianni R, Salvatori R, et al. Absorbed dose to lesion and clinical outcome after liver radioembolization with 90Y microspheres: a case report of PET-based dosimetry. Ann Nucl Med. 2013;27:676\u201380. https:\/\/doi.org\/10.1007\/s12149-013-0726-4.","journal-title":"Ann Nucl Med"},{"key":"1240_CR17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1120\/jacmp.v14i5.4371","volume":"14","author":"SC Ng","year":"2013","unstructured":"Ng SC, Lee VH, Law MW, Liu RK, Ma VW, Tso WK, et al. Patient dosimetry for 90Y selective internal radiation treatment based on 90Y PET imaging. J Appl Clin Med Phys. 2013;14:212\u201321. https:\/\/doi.org\/10.1120\/jacmp.v14i5.4371.","journal-title":"J Appl Clin Med Phys"},{"key":"1240_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers15030645","volume":"15","author":"CS Taswell","year":"2023","unstructured":"Taswell CS, Studenski M, Pennix T, Stover B, Georgiou M, Venkat S, et al. For hepatocellular carcinoma treated with yttrium-90 microspheres, dose volumetrics on post-treatment bremsstrahlung SPECT\/CT predict clinical outcomes. Cancers. 2023;15:1\u201317. https:\/\/doi.org\/10.3390\/cancers15030645.","journal-title":"Cancers"},{"key":"1240_CR19","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.jvir.2024.05.020","volume":"35","author":"T Sandow","year":"2024","unstructured":"Sandow T, Gimenez J, Nunez K, Tramel R, Gilbert P, Oliver B, et al. Using voxel-based dosimetry to evaluate sphere concentration and tumor dose in hepatocellular carcinoma treated with yttrium-90 radiation segmentectomy with glass microspheres. J Vasc Interv Radiol. 2024;35:1602\u201312. https:\/\/doi.org\/10.1016\/j.jvir.2024.05.020.","journal-title":"J Vasc Interv Radiol"},{"key":"1240_CR20","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.jvir.2024.07.011","volume":"35","author":"AK Jones","year":"2024","unstructured":"Jones AK. Known unknowns: gaps in dose distribution in radioembolization, and in our understanding of them. J Vasc Interv Radiol. 2024;35:1613\u20135. https:\/\/doi.org\/10.1016\/j.jvir.2024.07.011.","journal-title":"J Vasc Interv Radiol"},{"key":"1240_CR21","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1007\/s00259-022-05902-w","volume":"49","author":"J Roosen","year":"2022","unstructured":"Roosen J, Westlund Gotby LE, Arntz MJ, F\u00fctterer JJ, Janssen MJ, Konijnenberg MW, et al. Intraprocedural MRI-based dosimetry during transarterial radioembolization of liver tumours with holmium-166 microspheres (EMERITUS-1): a phase I trial towards adaptive, image-controlled treatment delivery. Eur J Nucl Med Mol Imaging. 2022;49:4705\u201315. https:\/\/doi.org\/10.1007\/s00259-022-05902-w.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1240_CR22","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/bjs.10515","volume":"104","author":"R van Rijn","year":"2017","unstructured":"van Rijn R, Karimian N, Matton AP, Burlage LC, Westerkamp AC, van den Berg AP, et al. Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death. J British Surg. 2017;104:907\u201317. https:\/\/doi.org\/10.1002\/bjs.10515.","journal-title":"J British Surg"},{"key":"1240_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13215462","volume":"13","author":"J Roosen","year":"2021","unstructured":"Roosen J, Arntz MJ, Janssen MJ, de Jong SF, F\u00fctterer JJ, Overduin CG, et al. Development of an MRI-guided approach to selective internal radiation therapy using holmium-166 microspheres. Cancers. 2021;13:1\u201318. https:\/\/doi.org\/10.3390\/cancers13215462.","journal-title":"Cancers"},{"key":"1240_CR24","unstructured":"Terumo Europe NV. QuiremSpheres\u2122 Administration Procedure Manual. LC-80072 [05]. 2023. Available online: https:\/\/www.terumo-europe.com\/safetyandperformance\/safety-and-performance-information."},{"key":"1240_CR25","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/mp.16014","volume":"50","author":"J Roosen","year":"2023","unstructured":"Roosen J, van Wijk MW, Westlund Gotby LE, Arntz MJ, Janssen MJ, Lobeek D, et al. Improving MRI-based dosimetry for holmium-166 transarterial radioembolization using a nonrigid image registration for voxelwise \u0394R2* calculation. Med Phys. 2023;50:935\u201346. https:\/\/doi.org\/10.1002\/mp.16014.","journal-title":"Med Phys"},{"key":"1240_CR26","doi-asserted-by":"crossref","unstructured":"ICRU. Report 83: Prescribing, Recording, and Reporting Photon-beam Intensity-modulated Radiation Therapy (IMRT). J ICRU. 2010;10: 1\u201392","DOI":"10.1093\/jicru_ndq012"},{"key":"1240_CR27","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/art.1780341208","volume":"34","author":"LS Johnson","year":"1991","unstructured":"Johnson LS, Yanch JC. Absorbed dose profiles for radionuclides of frequent use in radiation synovectomy. Arthritis Rheum. 1991;34:1521\u201330. https:\/\/doi.org\/10.1002\/art.1780341208.","journal-title":"Arthritis Rheum"},{"key":"1240_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2014.00038","volume":"4","author":"AS Pasciak","year":"2014","unstructured":"Pasciak AS, Bourgeois AC, McKinney JM, Chang TT, Osborne DR, Acuff SN, et al. Radioembolization and the dynamic role of 90Y PET\/CT. Front Oncol. 2014;4:1\u201312. https:\/\/doi.org\/10.3389\/fonc.2014.00038.","journal-title":"Front Oncol"},{"key":"1240_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40658-022-00447-1","volume":"9","author":"EC Henry","year":"2022","unstructured":"Henry EC, Strugari M, Mawko G, Brewer K, Liu D, Gordon AC, et al. Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model. EJNMMI Phys. 2022;9:1\u201326. https:\/\/doi.org\/10.1186\/s40658-022-00447-1.","journal-title":"EJNMMI Phys"},{"key":"1240_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41747-020-00157-2","volume":"4","author":"R Bakker","year":"2020","unstructured":"Bakker R, Bastiaannet R, van Nimwegen S, Barten-van Rijbroek A, Van Es R, Rosenberg A, et al. Feasibility of CT quantification of intratumoural 166Ho-microspheres. European Radiol Experiment. 2020;4:1\u201311. https:\/\/doi.org\/10.1186\/s41747-020-00157-2.","journal-title":"European Radiol Experiment"},{"key":"1240_CR31","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jvir.2022.03.006","volume":"33","author":"A Taebi","year":"2022","unstructured":"Taebi A, Janibek N, Goldman R, Pillai R, Vu CT, Roncali E. The impact of injection distance to bifurcations on yttrium-90 distribution in liver cancer radioembolization. J Vasc Interv Radiol. 2022;33:668\u201377. https:\/\/doi.org\/10.1016\/j.jvir.2022.03.006.","journal-title":"J Vasc Interv Radiol"},{"key":"1240_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jvir.2022.07.032","volume":"34","author":"SR Miller","year":"2023","unstructured":"Miller SR, Jernigan SR, Abraham RJ, Buckner GD. Comparison of bolus versus dual-syringe administration systems on glass yttrium-90 microsphere deposition in an in vitro microvascular hepatic tumor model. J Vasc Interv Radiol. 2023;34:11\u201320. https:\/\/doi.org\/10.1016\/j.jvir.2022.07.032.","journal-title":"J Vasc Interv Radiol"},{"key":"1240_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10717544.2023.2226366","volume":"30","author":"T Snoeijink","year":"2023","unstructured":"Snoeijink T, Vlogman T, Roosen J, Groot Jebbink E, Jain K, Nijsen J. Transarterial radioembolization: a systematic review on gaining control over the parameters that influence microsphere distribution. Drug Delivery. 2023;30:1\u201313. https:\/\/doi.org\/10.1080\/10717544.2023.2226366.","journal-title":"Drug Delivery"},{"key":"1240_CR34","unstructured":"Terumo Europe NV. QuiremSpheres\u2122 Instructions For Use. LC-80043 [09]. 2024. Available online: https:\/\/www.terumo-europe.com\/safetyandperformance\/safety-and-performance-information."},{"key":"1240_CR35","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.2967\/jnumed.122.263823","volume":"63","author":"MT Reinders","year":"2022","unstructured":"Reinders MT, van Erpecum KJ, Smits ML, Braat AJ, de Bruijne J, Bruijnen R, et al. Safety and efficacy of 166Ho Radioembolization in hepatocellular carcinoma: the HEPAR primary study. J Nucl Med. 2022;63:1891\u20138. https:\/\/doi.org\/10.2967\/jnumed.122.263823.","journal-title":"J Nucl Med"},{"key":"1240_CR36","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/s1470-2045(12)70334-0","volume":"13","author":"ML Smits","year":"2012","unstructured":"Smits ML, Nijsen JF, van den Bosch MA, Lam MG, Vente MA, Mali WP, et al. Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study. Lancet Oncol. 2012;13:1025\u201334. https:\/\/doi.org\/10.1016\/s1470-2045(12)70334-0.","journal-title":"Lancet Oncol"},{"key":"1240_CR37","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00259-024-06940-2","volume":"52","author":"MT Reinders","year":"2025","unstructured":"Reinders MT, Braat AJ, van Erpecum KJ, de Bruijne J, Bruijnen RC, Sprengers D, et al. Holmium-166 radioembolisation dosimetry in HCC. Eur J Nucl Med Mol Imaging. 2025;52:993\u20131003. https:\/\/doi.org\/10.1007\/s00259-024-06940-2.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1240_CR38","doi-asserted-by":"publisher","first-page":"272","DOI":"10.2967\/jnumed.120.243832","volume":"62","author":"C van Roekel","year":"2021","unstructured":"van Roekel C, Bastiaannet R, Smits ML, Bruijnen RC, Braat AJ, de Jong HW, et al. Dose-effect relationships of 166Ho radioembolization in colorectal cancer. J Nucl Med. 2021;62:272\u20139. https:\/\/doi.org\/10.2967\/jnumed.120.243832.","journal-title":"J Nucl Med"},{"key":"1240_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-023-11280-9","volume":"23","author":"D Andel","year":"2023","unstructured":"Andel D, Lam MG, de Bruijne J, Smits ML, Braat AJ, Moelker A, et al. Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC: the RALLY protocol. BMC Cancer. 2023;23:1\u20139. https:\/\/doi.org\/10.1186\/s12885-023-11280-9.","journal-title":"BMC Cancer"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01240-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-025-01240-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01240-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T02:57:14Z","timestamp":1745809034000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-025-01240-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1240"],"URL":"https:\/\/doi.org\/10.1186\/s13550-025-01240-8","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University Medical Center Groningen Central ethics Review Board non-WMO studies approved the conduct of the study (ref 202000037). The Dutch law on organ donation rules that people who give permission for organ donation, automatically also provide consent for transplantation-related research with their organs if an organ is discarded, unless the person explicitly objected. For ethical reasons, however, written informed consent for research was obtained from the donors\u2019 relatives.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JFWN is co-founder and scientific advisor of Quirem Medical B.V., which has been acquired by Terumo Europe NV in July 2020. The activities of JFWN within Quirem Medical B.V. are approved and supported by the Board of Directors of the Radboudumc. JFWN is entitled to certain milestone payments from Terumo Europe NV which are related to the financial, operational and regulatory performance of Quirem Medical B.V. in the future; AGA is a senior scientist at Terumo Blood and Cell Technologies and is entitled to certain milestone payments from Terumo Europe NV which are related to the financial, operational and regulatory performance of Quirem Medical B.V. in the future. AGA is an inventor of a patent that is assigned to Quirem Medical B.V. related to particles comprising lanthanide hydroxides. The activities of AGA within the Radboudumc are approved and supported by Terumo; VEM reports a VENI research grant by the Dutch Research Council (ZonMW\/NWO; grant #09150161810030), a Research grant from the Dutch Ministry of Economic Affairs (Health\u2009~\u2009Holland Public Private Partnership grant #PPP-2019\u2013024), and a Research grant from the Dutch Society for Gastroenterology (NVGE #01\u20132021), all outside the submitted work; The other authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}